Se rendre au contenu

The Invisible Toll

What a rigorous 2025 systematic review reveals about the biological cost of working with ionising radiation and why existing dose limits may not tell the whole story.A literature Review
27 mai 2026 par
The Invisible Toll
Paul Dixon
| Aucun commentaire pour l'instant
The Invisible Toll: Occupational Radiation Health in Healthcare Professionals
LENS OPACITIES DNA DAMAGE GENOTOXIC EFFECTS
Systematic Review  ·  Occupational Health

The
Invisible
Toll

What a rigorous 2025 systematic review reveals about the biological cost of working with ionising radiation — and why existing dose limits may not tell the whole story.

Lopes, Teles & Santos · 2025 J. Radiol. Prot. 45, 021002 32 studies · 2019–2023 PRISMA Methodology
345
articles identified in initial literature search across Scopus, PubMed & Web of Science
32
studies meeting full inclusion criteria after complete text screening
6
studies specifically reporting markers of DNA damage and genomic instability
5yr
study window — January 2019 to December 2023 — representing the most current evidence base
01 — Context

Low Dose, Long Career:
A Slowly Accumulating Risk

Healthcare professionals working with ionising radiation — radiologists, radiographers, interventional cardiologists, nuclear medicine technologists, radiotherapy staff — represent the largest single occupational group with chronic, low-level radiation exposure. Unlike high-dose, acute exposure scenarios, the health implications of years or decades of low-dose occupational exposure remain a subject of active scientific scrutiny.

The dominant regulatory framework, built around dose limits recommended by the International Commission on Radiological Protection, is designed on the assumption that risks scale linearly with dose and that compliance with limits ensures acceptable risk. What this 2025 systematic review — published in the Journal of Radiological Protection — asks is a more pointed question: even within those limits, what is the biological evidence of harm?

Exposure to low doses of ionising radiation can induce biological effects in healthcare professionals — including DNA damage, genotoxic effects, lens opacities, and risk of cancer.

Lopes, Teles & Santos — J. Radiol. Prot. 45, 021002 (2025)
02 — Methodology

How the Review
Was Constructed

The review followed PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), the internationally recognised standard for systematic review methodology. Articles were sourced from three major databases — Scopus, PubMed, and Web of Science — and restricted to publications in English from January 2019 to December 2023, ensuring the evidence base reflects the most current five-year period of research.

345
Initial Articles Found
Identified across Scopus, PubMed, and Web of Science using targeted keyword combinations
32
Included After Screening
Articles addressing adverse biological effects of ionising radiation in medical applications only
5yr
Study Window
2019–2023, representing the most contemporary evidence available at time of review

Inclusion required that studies specifically addressed adverse biological effects in healthcare professionals in medical applications — excluding general population, patient, or industrial radiation exposure studies. The professions covered spanned interventional cardiology, radiology (diagnostic and interventional), radiotherapy, and nuclear medicine.

03 — Key Findings

Four Categories
of Biological Impact

The review identified four primary areas where the evidence of biological effect from occupational radiation exposure is consistent and substantiated. These are not theoretical risks extrapolated from high-dose studies — they are biological markers measured directly in exposed healthcare workers.

DNA
DNA Damage & Genomic Instability
Markers of DNA damage were reported in six studies within the review, with findings of micronuclei, chromosomal aberrations, and genotoxic effects in exposed workers. The review emphasises the potential for ongoing genomic instability even at occupational doses well within current limits.
👁
Lens Opacities & Cataract Risk
Lens opacities — a precursor to radiation-induced cataracts — were significantly noted across the review, with the finding particularly pronounced among interventional radiologists and cardiologists. This is consistent with the ICRP's 2011 revision lowering the occupational lens dose limit from 150 mSv to 20 mSv per year.
Genotoxic Effects
Beyond direct DNA strand breaks, the review documents genotoxic effects — damage to genetic material with the potential to interfere with normal cellular replication. These effects are measurable at the dose levels characteristic of regular occupational exposure in high-intensity departments.
Cancer Risk
The review identifies elevated cancer risk as a documented concern in the literature, particularly for staff in fluoroscopy-intensive roles. The evidence is consistent with the linear no-threshold model of radiation carcinogenesis, which holds that no dose is entirely without risk.
04 — Who Is Most at Risk?

Speciality Matters:
Interventional Staff Lead Exposure

The review's breakdown of included studies by clinical speciality reveals where the evidence of biological impact is most concentrated. Of the 32 studies meeting inclusion criteria, five focused specifically on interventional cardiologists — a cohort particularly well-represented in the genotoxicity and lens opacity literature. Nineteen studies included radiology and radiotherapy department staff, reflecting the breadth of occupational exposure across imaging specialities.

Interventional cardiology emerges as a speciality of particular concern, owing to the combination of high fluoroscopy time per procedure, close operator proximity to the radiation source, and the cumulative nature of exposure over a long career of high-volume procedural work. The biological evidence documented in the review is, for this group, extensive and specific.

Highest-Risk Occupational Profiles
  • Interventional cardiologists — high fluoroscopy time, proximity to source, large procedural volume
  • Interventional radiologists — similar exposure profile to interventional cardiology
  • Radiographers in fluoroscopy and high-throughput diagnostic settings
  • Nuclear medicine staff with chronic internal contamination risk
  • Radiotherapy staff involved in dosimetric and quality assurance work
05 — The Broader Picture

Dose Limits Are a Floor,
Not a Guarantee

Perhaps the most important conceptual contribution of this review is the implicit challenge it poses to complacency about dose limit compliance. Current regulatory limits — 20 mSv per year averaged over five years for whole-body dose, with a 50 mSv ceiling in any single year — are designed as the upper boundary of acceptable occupational exposure, not a safe threshold below which no biological effect occurs.

The evidence reviewed by Lopes, Teles and Santos documents measurable biological effects — chromosomal aberrations, elevated micronuclei frequency, lens changes, genotoxic markers — in workers whose recorded doses fall within those limits. This is not a contradiction of the regulatory framework; it is a reflection of the linear no-threshold model on which that framework is built. The implication is that minimising dose, rather than simply staying within limits, remains the appropriate professional and institutional standard.

The evidence of genomic instability and lens changes in workers within dose limits reinforces that ALARA — as low as reasonably achievable — is not a compliance slogan. It is a clinical and ethical imperative.

The ALARA principle (as low as reasonably achievable) has been the cornerstone of radiation protection practice for decades. This review's findings are a reminder of the biological rationale behind it — and of the importance of protective equipment, dose monitoring, technique optimisation, and departmental culture in keeping occupational exposure genuinely minimal.

06 — Implications

What This Means
for Radiation Protection Practice

The systematic review does not prescribe clinical solutions — its purpose is to characterise the evidence base, not to evaluate interventions. But the findings have clear implications for how departments, employers, and individual practitioners should approach occupational radiation protection.

Practical Implications from the Evidence
  • Dose monitoring must be rigorous and consistent — personal dosimetry data should be actively reviewed, not merely filed
  • Protective equipment integrity matters: a compromised apron or thyroid collar is not a minor inconvenience, it is an unmonitored dose increment
  • Eye protection (lead glasses) is no longer optional for high-exposure roles — lens opacity data in interventional staff is consistent and significant
  • ALARA culture must be reinforced institutionally, not left to individual practitioners to observe under procedural pressure
  • Staff in high-intensity fluoroscopy roles should have access to regular occupational health review informed by dosimetry history
  • Protective garment quality should be evaluated not only on initial specification but on verified performance under real scatter conditions
Source Lopes, R., Teles, P. and Santos, J. (2025). A systematic review on the occupational health impacts of ionising radiation exposure among healthcare professionals. Journal of Radiological Protection, 45(2), 021002. doi: 10.1088/1361-6498/added2


The Invisible Toll
Paul Dixon 27 mai 2026
Partager cet article
Archive
Se connecter pour laisser un commentaire.